clinical implications of loss of minimal residual disease (mrd) negativity in multiple myeloma
Published 4 years ago • 390 plays • Length 4:53Download video MP4
Download video MP3
Similar videos
-
4:10
how does minimal residual disease (mrd) testing affect treatment decisions?
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?
-
3:44
what is mrd, or minimal residual disease?
-
1:59
mrd negativity as predictors of early relapse in transplant-eligible multiple myeloma patients
-
19:41
multiple myeloma: minimal residual disease
-
12:09
mrd2stop: can multimodal mrd negativity guide discontinuation of maintenance treatment in myeloma?
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
3:18
what does it mean when a myeloma patient is mrd negative?
-
3:38
three key messages for mrd negativity in multiple myeloma
-
2:28
what is minimal residual disease (mrd) and how can it help speed up new myeloma drug approvals?
-
3:23
mrd-directed trials & achieving mrd negativity in patients with high-risk multiple myeloma
-
0:34
medical animation: multiple myeloma minimal residual disease (mrd)
-
1:33
dr. valent on mrd negativity in multiple myeloma
-
11:23
challenges and future perspectives for minimal residual disease (mrd) in multiple myeloma
-
8:44
evolving role of mrd negativity in multiple myeloma
-
1:04
the value of mrd in transplant-ineligible patients with multiple myeloma
-
1:20
mrd in myeloma